More strikingly, the NSCLC patients with any positive of p-Akt, p-mTOR and p-eIF4E proteins had shorter OS than those with all negative expression (P = 0.011, Fig 3D). This evidence concerns the gene MTOR and non-small cell lung carcinoma.